Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Kochanowicz

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Biomedicines|January 25, 2025
Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl FumarateMarcin Bazylewicz, Monika Zajkowska, Monika Gudowska-Sawczuk, et al.
Advances in Medical Sciences|March 21, 2021
Transnasal endoscopic skull base surgery in the COVID-19 era: Recommendations for increasing the safety of the methodTomasz Lyson, Joanna Kisluk, Marek Alifier, et al.
Neurologia I Neurochirurgia Polska|March 29, 2020
Clinical and epidemiological characteristics of multiple sclerosis patients receiving disease-modifying treatment in PolandKatarzyna Kapica-Topczewska, Francois Collin, Joanna Tarasiuk, et al.
Vaccines|March 28, 2024
Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory TherapiesJoanna Kulikowska, Katarzyna Kapica-Topczewska, Monika Gudowska-Sawczuk, et al.
Journal of Neurochemistry|June 26, 2024
20S constitutive proteasome, 20S immunoproteasome, and cathepsin S are high-sensitivity and independent markers of immunological activity in relapsing-remitting type of multiple sclerosisEwelina Górska, Marzena Tylicka, Joanna Kamińska, et al.
Scientific Reports|December 12, 2023
Multiple sclerosis susceptibility may be associated with the coding rs20541 (R130Q) IL-13 gene polymorphism in the Polish populationCezary Grunwald, Edyta Adamska-Patruno, Natalia Wawrusiewicz-Kurylonek, et al.
Scientific Reports|March 1, 2023
UCHL1, besides leptin and fibronectin, also could be a sensitive marker of the relapsing-remitting type of multiple sclerosisEwelina Górska, Marzena Tylicka, Adam Hermanowicz, et al.
Immunobiology|November 18, 2019
The interferon-induced helicase C domain-containing protein 1 gene variant (rs1990760) as an autoimmune-based pathology susceptibility factorNatalia Wawrusiewicz-Kurylonek, Joanna Gościk, Monika Chorąży, et al.
Neurologia I Neurochirurgia Polska|May 30, 2025
Assessment of redox balance parameters among patients with acute ischaemic strokeAnna Mirończuk, Katarzyna Kapica Topczewska, Jacek Jamiołkowski, et al.
Nanomedicine (London, England)|October 22, 2020
Rod-shaped gold nanoparticles exert potent candidacidal activity and decrease the adhesion of fungal cellsEwelina Piktel, Łukasz Suprewicz, Joanna Depciuch, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Biomedicines|January 25, 2025
Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl FumarateMarcin Bazylewicz, Monika Zajkowska, Monika Gudowska-Sawczuk, et al.
Advances in Medical Sciences|March 21, 2021
Transnasal endoscopic skull base surgery in the COVID-19 era: Recommendations for increasing the safety of the methodTomasz Lyson, Joanna Kisluk, Marek Alifier, et al.
Neurologia I Neurochirurgia Polska|March 29, 2020
Clinical and epidemiological characteristics of multiple sclerosis patients receiving disease-modifying treatment in PolandKatarzyna Kapica-Topczewska, Francois Collin, Joanna Tarasiuk, et al.
Vaccines|March 28, 2024
Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory TherapiesJoanna Kulikowska, Katarzyna Kapica-Topczewska, Monika Gudowska-Sawczuk, et al.
Journal of Neurochemistry|June 26, 2024
20S constitutive proteasome, 20S immunoproteasome, and cathepsin S are high-sensitivity and independent markers of immunological activity in relapsing-remitting type of multiple sclerosisEwelina Górska, Marzena Tylicka, Joanna Kamińska, et al.
Scientific Reports|December 12, 2023
Multiple sclerosis susceptibility may be associated with the coding rs20541 (R130Q) IL-13 gene polymorphism in the Polish populationCezary Grunwald, Edyta Adamska-Patruno, Natalia Wawrusiewicz-Kurylonek, et al.
Scientific Reports|March 1, 2023
UCHL1, besides leptin and fibronectin, also could be a sensitive marker of the relapsing-remitting type of multiple sclerosisEwelina Górska, Marzena Tylicka, Adam Hermanowicz, et al.
Immunobiology|November 18, 2019
The interferon-induced helicase C domain-containing protein 1 gene variant (rs1990760) as an autoimmune-based pathology susceptibility factorNatalia Wawrusiewicz-Kurylonek, Joanna Gościk, Monika Chorąży, et al.
Neurologia I Neurochirurgia Polska|May 30, 2025
Assessment of redox balance parameters among patients with acute ischaemic strokeAnna Mirończuk, Katarzyna Kapica Topczewska, Jacek Jamiołkowski, et al.
Nanomedicine (London, England)|October 22, 2020
Rod-shaped gold nanoparticles exert potent candidacidal activity and decrease the adhesion of fungal cellsEwelina Piktel, Łukasz Suprewicz, Joanna Depciuch, et al.
Pageof 12